메뉴 건너뛰기




Volumn 2, Issue 1, 2012, Pages

Minocycline and aspirin in the treatment of bipolar depression: A protocol for a proof-of-concept, randomised, doubleblind, placebo-controlled, 232 clinical trial

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CARBAMAZEPINE; CYCLOOXYGENASE 1; CYTOKINE; FLUOXETINE; LAMOTRIGINE; LITHIUM; MINOCYCLINE; PLACEBO; VALPROIC ACID;

EID: 84857822431     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000643     Document Type: Review
Times cited : (68)

References (95)
  • 1
    • 78149360952 scopus 로고    scopus 로고
    • Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
    • Correa R, Akiskal H, Gilmer W, et al. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord 2010;127:10-18.
    • (2010) J Affect Disord , vol.127 , pp. 10-18
    • Correa, R.1    Akiskal, H.2    Gilmer, W.3
  • 5
    • 70350136882 scopus 로고    scopus 로고
    • Revisiting the effectiveness of standard antidepressants in bipolar disorder: Are monoamine oxidase inhibitors superior?
    • Mallinger AG, Frank E, Thase ME, et al. Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior? Psychopharmacol Bull 2009;42:64-74.
    • (2009) Psychopharmacol Bull , vol.42 , pp. 64-74
    • Mallinger, A.G.1    Frank, E.2    Thase, M.E.3
  • 6
    • 0025860380 scopus 로고
    • Tranylcypromine versus imipramine in anergic bipolar depression
    • Himmelhoch JM, Thase ME, Mallinger AG, et al. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148:910-16.
    • (1991) Am J Psychiatry , vol.148 , pp. 910-916
    • Himmelhoch, J.M.1    Thase, M.E.2    Mallinger, A.G.3
  • 7
    • 0026595036 scopus 로고
    • Treatment of imipramineresistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression
    • Thase ME, Mallinger AG, McKnight D, et al. Treatment of imipramineresistant recurrent depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992;149:195-8.
    • (1992) Am J Psychiatry , vol.149 , pp. 195-198
    • Thase, M.E.1    Mallinger, A.G.2    McKnight, D.3
  • 8
    • 64549126898 scopus 로고    scopus 로고
    • Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
    • Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 2009;33:699-771.
    • (2009) Neurosci Biobehav Rev , vol.33 , pp. 699-771
    • Savitz, J.1    Drevets, W.C.2
  • 9
    • 74049093658 scopus 로고    scopus 로고
    • Imaging phenotypes of major depressive disorder: Genetic correlates
    • Savitz JB, Drevets WC. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009;164:300-30.
    • (2009) Neuroscience , vol.164 , pp. 300-330
    • Savitz, J.B.1    Drevets, W.C.2
  • 10
    • 78650035858 scopus 로고    scopus 로고
    • Molecular and cellular mechanisms of excitotoxic neuronal death
    • Wang Y, Qin ZH. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 2010;15:1382-402.
    • (2010) Apoptosis , vol.15 , pp. 1382-1402
    • Wang, Y.1    Qin, Z.H.2
  • 11
    • 77954993010 scopus 로고    scopus 로고
    • An update on the role of glutamate in the pathophysiology of depression
    • Mitchell ND, Baker GB. An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr Scand 2010;122:192-210.
    • (2010) Acta Psychiatr Scand , vol.122 , pp. 192-210
    • Mitchell, N.D.1    Baker, G.B.2
  • 12
    • 67649238182 scopus 로고    scopus 로고
    • Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression
    • Ryan B, Musazzi L, Mallei A, et al. Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol 2009;12:553-9.
    • (2009) Int J Neuropsychopharmacol , vol.12 , pp. 553-559
    • Ryan, B.1    Musazzi, L.2    Mallei, A.3
  • 13
    • 33746902947 scopus 로고    scopus 로고
    • Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice
    • DOI 10.1038/sj.npp.1301039, PII 1301039
    • Boyce-Rustay JM, Holmes A. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 2006;31:2405-14. (Pubitemid 44607058)
    • (2006) Neuropsychopharmacology , vol.31 , Issue.11 , pp. 2405-2414
    • Boyce-Rustay, J.M.1    Holmes, A.2
  • 14
    • 67649220685 scopus 로고    scopus 로고
    • Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population
    • Tsunoka T, Kishi T, Ikeda M, et al. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:875-9.
    • (2009) Prog Neuropsychopharmacol Biol Psychiatry , vol.33 , pp. 875-879
    • Tsunoka, T.1    Kishi, T.2    Ikeda, M.3
  • 15
    • 77955891255 scopus 로고    scopus 로고
    • A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
    • Diazgranados N, Ibrahim L, Brutsche NE, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010;67:793-802.
    • (2010) Arch Gen Psychiatry , vol.67 , pp. 793-802
    • Diazgranados, N.1    Ibrahim, L.2    Brutsche, N.E.3
  • 17
    • 75849155537 scopus 로고    scopus 로고
    • A meta-analysis of cytokines in major depression
    • Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-57.
    • (2010) Biol Psychiatry , vol.67 , pp. 446-457
    • Dowlati, Y.1    Herrmann, N.2    Swardfager, W.3
  • 18
    • 70449376943 scopus 로고    scopus 로고
    • Cytokines and glucocorticoid receptor signaling. Relevance to major depression
    • Pace TW, Miller AH. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci 2009;1179:86-105.
    • (2009) Ann N y Acad Sci , vol.1179 , pp. 86-105
    • Pace, T.W.1    Miller, A.H.2
  • 19
    • 0026552955 scopus 로고
    • Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness
    • Maes M, Scharpe S, Van Grootel L, et al. Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 1992;24:183-92.
    • (1992) J Affect Disord , vol.24 , pp. 183-192
    • Maes, M.1    Scharpe, S.2    Van Grootel, L.3
  • 20
    • 15744394859 scopus 로고    scopus 로고
    • Inflammatory markers and sleep disturbance in major depression
    • DOI 10.1097/01.psy.0000149259.72488.09
    • Motivala SJ, Sarfatti A, Olmos L, et al. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005;67:187-94. (Pubitemid 40410952)
    • (2005) Psychosomatic Medicine , vol.67 , Issue.2 , pp. 187-194
    • Motivala, S.J.1    Sarfatti, A.2    Olmos, L.3    Irwin, M.R.4
  • 21
    • 0028258379 scopus 로고
    • Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls
    • DOI 10.1016/0165-0327(94)90135-X
    • Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 1994;30:283-8. (Pubitemid 24115279)
    • (1994) Journal of Affective Disorders , vol.30 , Issue.4 , pp. 283-288
    • Song, C.1
  • 23
    • 74949090006 scopus 로고    scopus 로고
    • The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder
    • Drexhage RC, Knijff EM, Padmos RC, et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 2010;10:59-76.
    • (2010) Expert Rev Neurother , vol.10 , pp. 59-76
    • Drexhage, R.C.1    Knijff, E.M.2    Padmos, R.C.3
  • 24
    • 0035035367 scopus 로고    scopus 로고
    • The immune system, depression and the action of antidepressants
    • DOI 10.1016/S0278-5846(01)00155-5, PII S0278584601001555
    • Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:767-80. (Pubitemid 32374966)
    • (2001) Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.25 , Issue.4 , pp. 767-780
    • Leonard, B.E.1
  • 25
    • 37249094173 scopus 로고    scopus 로고
    • From inflammation to sickness and depression: When the immune system subjugates the brain
    • DOI 10.1038/nrn2297, PII NRN2297
    • Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56. (Pubitemid 350295688)
    • (2008) Nature Reviews Neuroscience , vol.9 , Issue.1 , pp. 46-56
    • Dantzer, R.1    O'Connor, J.C.2    Freund, G.G.3    Johnson, R.W.4    Kelley, K.W.5
  • 26
    • 79954598830 scopus 로고    scopus 로고
    • Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
    • Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:664-75.
    • (2011) Prog Neuropsychopharmacol Biol Psychiatry , vol.35 , pp. 664-675
    • Maes, M.1
  • 27
    • 63449122724 scopus 로고    scopus 로고
    • Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression
    • Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-41.
    • (2009) Biol Psychiatry , vol.65 , pp. 732-741
    • Miller, A.H.1    Maletic, V.2    Raison, C.L.3
  • 28
    • 0033305459 scopus 로고    scopus 로고
    • The proinflammatory cytokine, interleukin-1α, reduces glucocorticoid receptor translocation and function
    • Pariante CM, Pearce BD, Pisell TL, et al. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999;140:4359-66. (Pubitemid 30647135)
    • (1999) Endocrinology , vol.140 , Issue.9 , pp. 4359-4366
    • Pariante, C.M.1    Pearce, B.D.2    Pisell, T.L.3    Sanchez, C.I.4    Po, C.5    Su, C.6    Miller, A.H.7
  • 30
    • 77950022119 scopus 로고    scopus 로고
    • CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFNalpha: Relationship to CNS immune responses and depression
    • Raison CL, Dantzer R, Kelley KW, et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFNalpha: relationship to CNS immune responses and depression. Mol Psychiatry 2010;15:393-403.
    • (2010) Mol Psychiatry , vol.15 , pp. 393-403
    • Raison, C.L.1    Dantzer, R.2    Kelley, K.W.3
  • 31
    • 77954509277 scopus 로고    scopus 로고
    • The possible role of the kynurenine pathway in adolescent depression with melancholic features
    • Gabbay V, Klein RG, Katz Y, et al. The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry 2010;51:935-43.
    • (2010) J Child Psychol Psychiatry , vol.51 , pp. 935-943
    • Gabbay, V.1    Klein, R.G.2    Katz, Y.3
  • 33
    • 11244317215 scopus 로고    scopus 로고
    • The potential of minocycline for neuroprotection in human neurologic disease
    • DOI 10.1097/01.wnf.0000150867.98887.3e
    • Zemke D, Majid A. The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 2004;27:293-8. (Pubitemid 40066232)
    • (2004) Clinical Neuropharmacology , vol.27 , Issue.6 , pp. 293-298
    • Zemke, D.1    Majid, A.2
  • 34
    • 33645662983 scopus 로고    scopus 로고
    • Minocycline for short-term neuroprotection
    • Elewa HF, Hilali H, Hess DC, et al. Minocycline for short-term neuroprotection. Pharmacotherapy 2006;26:515-21.
    • (2006) Pharmacotherapy , vol.26 , pp. 515-521
    • Elewa, H.F.1    Hilali, H.2    Hess, D.C.3
  • 35
    • 39149117362 scopus 로고    scopus 로고
    • Immunosuppression after traumatic or ischemic CNS damage: It is neuroprotective and illuminates the role of microglial cells
    • Hailer NP. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 2008;84:211-33.
    • (2008) Prog Neurobiol , vol.84 , pp. 211-233
    • Hailer, N.P.1
  • 36
    • 44349129208 scopus 로고    scopus 로고
    • Does minocycline have antidepressant effect?
    • DOI 10.1016/j.biopha.2007.12.005, PII S0753332207002880
    • Pae CU, Marks DM, Han C, et al. Does minocycline have antidepressant effect? Biomed Pharmacother 2008;62:308-11. (Pubitemid 351749775)
    • (2008) Biomedicine and Pharmacotherapy , vol.62 , Issue.5 , pp. 308-311
    • Pae, C.-U.1    Marks, D.M.2    Han, C.3    Patkar, A.A.4
  • 38
    • 0032956630 scopus 로고    scopus 로고
    • The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS
    • DOI 10.1046/j.1471-4159.1999.720879.x
    • Chen G, Zeng WZ, Yuan PX, et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999;72:879-82. (Pubitemid 29055256)
    • (1999) Journal of Neurochemistry , vol.72 , Issue.2 , pp. 879-882
    • Chen, G.1    Zeng, W.-Z.2    Yuan, P.-X.3    Huang, L.-D.4    Jiang, Y.-M.5    Zhao, Z.-H.6    Manji, H.K.7
  • 39
    • 43649084022 scopus 로고    scopus 로고
    • Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures
    • DOI 10.1038/sj.npp.1301527, PII 1301527
    • Kosten TA, Galloway MP, Duman RS, et al. Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 2008;33:1545-58. (Pubitemid 351684697)
    • (2008) Neuropsychopharmacology , vol.33 , Issue.7 , pp. 1545-1558
    • Kosten, T.A.1    Galloway, M.P.2    Duman, R.S.3    Russell, D.S.4    D'Sa, C.5
  • 40
    • 37549048249 scopus 로고    scopus 로고
    • The BCL-2 protein family: Opposing activities that mediate cell death
    • Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47-59.
    • (2008) Nat Rev Mol Cell Biol , vol.9 , pp. 47-59
    • Youle, R.J.1    Strasser, A.2
  • 41
    • 79551681952 scopus 로고    scopus 로고
    • Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation
    • Bailey MT, Dowd SE, Galley JD, et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 2011;25:397-407.
    • (2011) Brain Behav Immun , vol.25 , pp. 397-407
    • Bailey, M.T.1    Dowd, S.E.2    Galley, J.D.3
  • 42
    • 0035871840 scopus 로고    scopus 로고
    • Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
    • Tikka T, Fiebich BL, Goldsteins G, et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001;21:2580-8. (Pubitemid 32298200)
    • (2001) Journal of Neuroscience , vol.21 , Issue.8 , pp. 2580-2588
    • Tikka, T.1    Fiebich, B.L.2    Goldsteins, G.3    Keinanen, R.4    Koistinaho, J.5
  • 45
    • 0034998271 scopus 로고    scopus 로고
    • Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction
    • discussion 99-401
    • Sanchez Mejia RO, Ona VO, Li M, et al. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001;48:1393-9; discussion 99-401.
    • (2001) Neurosurgery , vol.48 , pp. 1393-1399
    • Sanchez Mejia, R.O.1    Ona, V.O.2    Li, M.3
  • 46
    • 62149089881 scopus 로고    scopus 로고
    • Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model
    • Bilousova TV, Dansie L, Ngo M, et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 2009;46:94-102.
    • (2009) J Med Genet , vol.46 , pp. 94-102
    • Bilousova, T.V.1    Dansie, L.2    Ngo, M.3
  • 47
  • 48
    • 33746635469 scopus 로고    scopus 로고
    • Protective effects of minocycline on 3,4-methylenedioxymethamphetamine- induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain
    • DOI 10.1016/j.ejphar.2006.05.047, PII S0014299906005413
    • Zhang L, Shirayama Y, Shimizu E, et al. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Eur J Pharmacol 2006;544:1-9. (Pubitemid 44148565)
    • (2006) European Journal of Pharmacology , vol.544 , Issue.1-3 , pp. 1-9
    • Zhang, L.1    Shirayama, Y.2    Shimizu, E.3    Iyo, M.4    Hashimoto, K.5
  • 49
    • 0026643124 scopus 로고
    • Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage
    • Greenwald RA, Moak SA, Ramamurthy NS, et al. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992;19:927-38.
    • (1992) J Rheumatol , vol.19 , pp. 927-938
    • Greenwald, R.A.1    Moak, S.A.2    Ramamurthy, N.S.3
  • 50
    • 0036260089 scopus 로고    scopus 로고
    • Targeting leukocyte MMPs and transmigration minocycline as a potential therapy for multiple sclerosis
    • Brundula V, Rewcastle NB, Metz LM, et al. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002;125:1297-308. (Pubitemid 34587139)
    • (2002) Brain , vol.125 , Issue.6 , pp. 1297-1308
    • Brundula, V.1    Rewcastle, N.B.2    Metz, L.M.3    Bernard, C.C.4    Yong, V.W.5
  • 57
    • 60849097905 scopus 로고    scopus 로고
    • Minocycline as adjunctive therapy for schizophrenia: An open-label study
    • Miyaoka T, Yasukawa R, Yasuda H, et al. Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol 2008;31:287-92.
    • (2008) Clin Neuropharmacol , vol.31 , pp. 287-292
    • Miyaoka, T.1    Yasukawa, R.2    Yasuda, H.3
  • 58
    • 77649112679 scopus 로고    scopus 로고
    • A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia
    • Levkovitz Y, Mendlovich S, Riwkes S, et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 2010;71:138-49.
    • (2010) J Clin Psychiatry , vol.71 , pp. 138-149
    • Levkovitz, Y.1    Mendlovich, S.2    Riwkes, S.3
  • 60
    • 51549109111 scopus 로고    scopus 로고
    • Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats
    • Molina-Hernandez M, Tellez-Alcantara NP, Perez-Garcia J, et al. Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1660-6.
    • (2008) Prog Neuropsychopharmacol Biol Psychiatry , vol.32 , pp. 1660-1666
    • Molina-Hernandez, M.1    Tellez-Alcantara, N.P.2    Perez-Garcia, J.3
  • 61
    • 65349135346 scopus 로고    scopus 로고
    • Lipopolysaccharideinduced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
    • O'Connor JC, Lawson MA, Andre C, et al. Lipopolysaccharideinduced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009;14:511-22.
    • (2009) Mol Psychiatry , vol.14 , pp. 511-522
    • O'Connor, J.C.1    Lawson, M.A.2    Andre, C.3
  • 64
    • 62949176283 scopus 로고    scopus 로고
    • The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications for translational research
    • Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 2009;30:174-81.
    • (2009) Trends Pharmacol Sci , vol.30 , pp. 174-181
    • Choi, S.H.1    Aid, S.2    Bosetti, F.3
  • 65
    • 77957127862 scopus 로고    scopus 로고
    • Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain
    • Choi SH, Aid S, Choi U, et al. Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain. Pharmacogenomics J 2010;10:448-57.
    • (2010) Pharmacogenomics J , vol.10 , pp. 448-457
    • Choi, S.H.1    Aid, S.2    Choi, U.3
  • 66
    • 77953953898 scopus 로고    scopus 로고
    • Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid
    • Choi SH, Bosetti F. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid. Aging (Albany NY) 2009;1:234-44.
    • (2009) Aging (Albany NY) , vol.1 , pp. 234-244
    • Choi, S.H.1    Bosetti, F.2
  • 67
    • 0038673579 scopus 로고    scopus 로고
    • Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain
    • Bosetti F, Weerasinghe GR, Rosenberger TA, et al. Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J Neurochem 2003;85:690-6. (Pubitemid 36531932)
    • (2003) Journal of Neurochemistry , vol.85 , Issue.3 , pp. 690-696
    • Bosetti, F.1    Weerasinghe, G.R.2    Rosenberger, T.A.3    Rapoport, S.I.4
  • 68
    • 3042831868 scopus 로고    scopus 로고
    • 2 or lipoxygenase/cytochrome P450 pathways
    • DOI 10.1016/j.brainresbull.2004.04.005, PII S0361923004001029
    • Weerasinghe GR, Rapoport SI, Bosetti F. The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res Bull 2004;63:485-9. (Pubitemid 38891858)
    • (2004) Brain Research Bulletin , vol.63 , Issue.6 , pp. 485-489
    • Weerasinghe, G.R.1    Rapoport, S.I.2    Bosetti, F.3
  • 69
    • 80053580791 scopus 로고    scopus 로고
    • Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: Implications for its efficacy in bipolar disorder
    • Ramadan E, Basselin M, Rao JS, et al. Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder. Int J Neuropsychopharmacol 2011:1-13.
    • (2011) Int J Neuropsychopharmacol , pp. 1-13
    • Ramadan, E.1    Basselin, M.2    Rao, J.S.3
  • 70
    • 73949141013 scopus 로고    scopus 로고
    • Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder
    • Stolk P, Souverein PC, Wilting I, et al. Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids 2010;82:9-14.
    • (2010) Prostaglandins Leukot Essent Fatty Acids , vol.82 , pp. 9-14
    • Stolk, P.1    Souverein, P.C.2    Wilting, I.3
  • 71
    • 0344119574 scopus 로고    scopus 로고
    • Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs
    • Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 2003;64:1328-34. (Pubitemid 37490238)
    • (2003) Journal of Clinical Psychiatry , vol.64 , Issue.11 , pp. 1328-1334
    • Phelan, K.M.1    Mosholder, A.D.2    Lu, S.3
  • 72
    • 33646708039 scopus 로고    scopus 로고
    • Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study
    • DOI 10.1097/00004850-200607000-00005, PII 0000485020060700000005
    • Mendlewicz J, Kriwin P, Oswald P, et al. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 2006;21:227-31. (Pubitemid 43740300)
    • (2006) International Clinical Psychopharmacology , vol.21 , Issue.4 , pp. 227-231
    • Mendlewicz, J.1    Kriwin, P.2    Oswald, P.3    Souery, D.4    Alboni, S.5    Brunello, N.6
  • 76
    • 67650083320 scopus 로고    scopus 로고
    • Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial
    • Akhondzadeh S, Jafari S, Raisi F, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 2009;26:607-11.
    • (2009) Depress Anxiety , vol.26 , pp. 607-611
    • Akhondzadeh, S.1    Jafari, S.2    Raisi, F.3
  • 77
    • 0037381058 scopus 로고    scopus 로고
    • Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition
    • DOI 10.1016/S0889-1591(03)00032-1
    • Maier SF. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun 2003;17:69-85. (Pubitemid 36369416)
    • (2003) Brain, Behavior, and Immunity , vol.17 , Issue.2 , pp. 69-85
    • Maier, S.F.1
  • 78
    • 65649152524 scopus 로고    scopus 로고
    • Associations of depression with Creactive protein, IL-1, and IL-6: A meta-analysis
    • Howren MB, Lamkin DM, Suls J. Associations of depression with Creactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-86.
    • (2009) Psychosom Med , vol.71 , pp. 171-186
    • Howren, M.B.1    Lamkin, D.M.2    Suls, J.3
  • 79
    • 60449111282 scopus 로고    scopus 로고
    • Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in pituitary physiology and pathophysiology
    • Renner U, De Santana EC, Gerez J, et al. Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in pituitary physiology and pathophysiology. Ann N Y Acad Sci 2009;1153:89-97.
    • (2009) Ann N y Acad Sci , vol.1153 , pp. 89-97
    • Renner, U.1    De Santana, E.C.2    Gerez, J.3
  • 81
    • 60749108941 scopus 로고    scopus 로고
    • MMRM vs. LOCF: A comprehensive comparison based on simulation study and 25 NDA datasets
    • Siddiqui O, Hung HM, O'Neill R. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. J Biopharm Stat 2009;19:227-46.
    • (2009) J Biopharm Stat , vol.19 , pp. 227-246
    • Siddiqui, O.1    Hung, H.M.2    O'neill, R.3
  • 84
    • 0034940379 scopus 로고    scopus 로고
    • Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: A focus on treatment-resistant depression
    • Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001;62(Suppl 16):5-9.
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 16 , pp. 5-9
    • Nierenberg, A.A.1    Dececco, L.M.2
  • 85
    • 69949169319 scopus 로고    scopus 로고
    • Meta-analysis of the placebo response in antidepressant trials
    • Rief W, Nestoriuc Y, Weiss S, et al. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 2009;118:1-8.
    • (2009) J Affect Disord , vol.118 , pp. 1-8
    • Rief, W.1    Nestoriuc, Y.2    Weiss, S.3
  • 88
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 90
    • 77951909982 scopus 로고    scopus 로고
    • Emotion recollected in tranquility: Lessons learned from the COX-2 saga
    • Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med 2010;61:17-33.
    • (2010) Annu Rev Med , vol.61 , pp. 17-33
    • Grosser, T.1    Yu, Y.2    Fitzgerald, G.A.3
  • 91
    • 4644289299 scopus 로고    scopus 로고
    • Platelet-active drugs: The relationships among dose, effectiveness, and side effects - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • DOI 10.1378/chest.126.3-suppl.234S
    • Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):234S-64S. (Pubitemid 39297956)
    • (2004) Chest , vol.126 , Issue.3 SUPPL.
    • Patrono, C.1    Coller, B.2    FitzGerald, G.A.3    Hirsh, J.4    Roth, G.5
  • 92
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • DOI 10.1016/S0140-6736(98)04311-6
    • Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62. (Pubitemid 28269185)
    • (1998) Lancet , vol.351 , Issue.9118 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6    Menard, J.7    Rahn, K.H.8    Wedel, H.9    Westerling, S.10
  • 93
  • 94
    • 0037027075 scopus 로고    scopus 로고
    • Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: A systematic review
    • Teo KK, Yusuf S, Pfeffer M, et al. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet 2002;360:1037-43.
    • (2002) Lancet , vol.360 , pp. 1037-1043
    • Teo, K.K.1    Yusuf, S.2    Pfeffer, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.